Introduction
Non-alcoholicfattyliverdisease(NAFLD)isdefined asalipidaccumulationexceeding5%ofhepatocytes. ItisestimatedthatNAFLDispresentin17-33%of the population in developed countries [1] . However, itsprevalenceamongobesepeoplemayreach70-80% [1] .NAFLDisrelatedtoincreasedmortalityrisk,with primarycausesofdeathbeingadvancedliverdisease, cardiovasculardisease,anddiabetesmellitus [2] .Cytokinesreleasedfromtheadiposetissuecalledadipokines seemtobeimportantcontributingfactorsinthedevelopmentofNAFLD(rangingfromsteatosistocirrhosis).Adipokinesarebelievedtoconstituteanimportant linkbetweenobesity,insulinresistance,andNAFLD. Oneoftheadipokinesisresistin.Inanimals,itismainly released from adipose tissue, while in humans it is released from macrophages [3] . The exact role of resistininthepathogenesisofNAFLDisambiguous.Its correlationwithliverinsulinresistance,steatosis,liver inflammation,andobesityhasbeensuggested [1, 3, 4] . 
Material and methods

Materials
Thestudyisaretrospectiveanalysis.Liverbiopsy specimenswereobtainedroutinelyviaintraoperative incisional biopsy from 214 morbidly obese patients operatedonattheChairandDepartmentofGeneral, Transplant,andLiverSurgery,MedicalUniversityof Warsawduringtheperiodfrom2005to2013.The controlgroupwasmadeupofspecimenstakenfrom 17patientswithnormalweightoperatedduetohae-mangiomasoftheliverbetween2002and2013.The specimens were embedded in paraffin blocks. They wereevaluatedbyoneexperiencedpathologistfrom theChairandDepartmentofPathologyoftheUniversityHospital.
The patients were qualified for bariatric surgery iftheirBMIwas≥40kg/m2oriftheirBMIwas≥ 35withatleastonecomorbidity,suchashypertension,type2diabetesmellitus,ordyslipidaemia.The mean age of patients was 42.3 years (range 19-65) andmeanBMIwas46.8(range33.5-71.6).Diabetes wasdiagnosedin42.1%,hypertensionin60.7%and dyslipidaemiain42.9%ofpatients.Womenaccountedfor63.1%ofthepatients.
Histology
Liver specimens were fixed in 4% formalin, and standardhaematoxylinandeosin(HE)stainingwas performed. The antigen retrieval was performed in PTLink(DAKO)inTargentRetrievalSolutionhighpHbuffer(DAKOK8004).Forimmunohistochemicalstaining,primaryanti-resistinmonoclonalmouse antibodywasused(Acris,AM01373PU-N,1:500di-lutioninAntibodyDiluent-DAKOEnVisionFlex K8006, visualization DAB). Immunohistochemistry was also performed with CD68 antibody (Flex MonoclonalMouseAnti-HumanCD68,CloneKP1, Ready-to-Use, DAKO GA609). To evaluate the fibrosis,SilverImpregnationforreticulum04-040801 wasused(Bio-Opticaspecialstainskit).
HistologicalassessmentwasbasedonNAFLDactivity score according to Kleiner [5] ; non-alcoholic steatohepatitis (NASH) was recognised if the score exceededfourpoints.HistologicalgroupcharacteristicsareshowninTableI.
The assessment of resistin expression was semi-quantitativein:
•thehistiocytes(macrophages)ofinflammatoryinfiltrate(0-3pts), •sinusoidalKupffercells(0-3pts), •histiocytes surrounding the hepatocytes with steatosis(0-3pts). Thetotalexpressionofresistinwasthesumofall points.
Expression was scored as the following: 0 -if therewasnoexpression,1-iftherewasexpression in1-10%cells,2-iftherewasexpressionin11-30% cells,3-iftherewasexpressionin>30%cells.
Statistical analysis
Statisticalanalysisincludedthecorrelations/differencesbetween: Chi-square test was used to investigate possible dependence of resistin expression in macrophages, Kupffer cells, and histiocytes surrounding the hepatocytes with steatosis upon the levels of the analysed binary variables (sex, dyslipidaemia, diabetes mellitus).UMann-Whitneytestwasusedtocheckif totalresistinlevelsdiffereddependingonthecategory of binary variables (sex, dyslipidaemia, diabetes). ANOVA(analysisofvariance)wasperformedtodeterminewhethermeanlevelsofcontinuousvariables dependedonthelevelofresistinexpression.Thecorrelationbetweentotalresistinexpressionandcontinuous variables was also investigated by calculating theSpearmancorrelationcoefficient.Pvalues<0.05 wereconsideredtobestatisticallysignificant.
Results
The assessment of resistin location in the liver showed: 1.Lackofresistinexpressioninhepatocytes. 2. Ineachcase,resistinexpressionwasnotedinhistiocytesoftheinfiltrate( Fig.1 ). 3. ExpressionofresistinintheKupffercells (Fig.2) , correlatedwithNASscale. 4. Resistin expression in histiocytes (CD68+) surrounding the steatotic hepatocytes ( Fig. 3) , correlatedpositivelywithNAFLDadvancement. TherewasapositivecorrelationofresistinexpressionwithKleinerNAFLDstatusinallbasicparam-eters: total NAS score, the level of hepatocyte steatosis, the severity of inflammation, and ballooning of hepatocytes (Table II) . This correlation was observedatalllocationsofanalysedresistinexpression: in the histiocytes of the inflammatory infiltrate, in theKupffercells,inhistiocytessurroundingthehepatocytes with steatosis, as well as in total resistin expression. No such correlation was observed with theseverityoforganfibrosisateitherofthelocations analysed, including the total assessment. Graphical interpretation for the total resistin expression is showninFig.4.
Analysis of resistin expression in the histiocytes of inflammatory infiltrate
Therewasastatisticallysignificantcorrelationwith the levels of glucose, HbA 1c , insulin, triglycerides, HOMAindex,andvitaminB 12 (TableIII).Forother biochemical parameters, statistical significance was p=0.074,andC-peptide:p=0.082).Nodifferences were observed between the study group and the controlgroup.Nostatisticallysignificantcorrelation was found with patient's age and BMI. The differenceinresistinexpressionwasnotnotedwithsex,hypertension,ormetformintreatment.Alsointhecase of dyslipidaemia the difference was not statistically significant(p=0.089).
Analysis of resistin expression in Kupffer cells
There was a statistically significant association with the levels of albumin, vitamin B 12 , and HDL cholesterol (Table III) 
Analysis of resistin expression in histiocytes surrounding the hepatocytes with steatosis
There was a statistically significant positive correlationwiththelevelof:AST,ALT,glucose,HbA 1c , insulin, triglycerides, and HOMA index (Table III) . For other biochemical parameters, statistical significance was not reached (in the case of: AST/ALT p=0.095andTC/HDLp=0.089).Nostatisticallysignificantcorrelationwasobservedwithpatient's age or BMI, and no difference was noted with sex, hypertension,ormetformintreatment.Inthecaseof diabetesmellitusanddyslipidaemiathedifferencein resistinexpressionwasclosetostatisticalsignificance (TableIII).Asignificantdifferencewasdemonstrated inresistinexpressionbetweenthecontrolgroupand thestudygroup.
Analysisoftotalresistinexpression(sumofexpressionsitesinmacrophagesoftheinflammatoryinfiltration,inKupffercellsandinhistiocytessurroundingthehepatocyteswithsteatosis).
There was a statistically significant positive correlation with the levels of: triglycerides, glucose, HbA 1c ,insulin,AST,ALT,LDH,GGTP,andHOMA index(TableIII).Forotherbiochemicalparameters, 
Discussion
The study is focused on diseases of high epidemiological importance (NAFLD, obesity). Adipokines have been the subject of great interest recently, but the results of published studies have been contradictory. There are various observations even regarding resistin location. Like only a few others [4, 5, 6, 7] , ourstudyisuniquebecauseresistinexpressionwasexamineddirectlyintheliver.Inourstudy,weconfirm that hepatocytes are not the source of resistin in the liver.Shenet al. [4] showedthattheimmunoreactivityforresistinwasprimarilylocatedinperisinusoidal cellsoftheliverlobules,rarelyinperiportalspace,and moremarkedininflammatoryspaces.Others [6] also pointtoKupffercellsandhepaticstellatecellsasthe mainplaceofresistinexpression.Szalowskaet al. [7] indicatedthatbesidesKupffercells,endotheliumcells andrarelyfibroblastsarealsotheplaceofresistinexpression. In our observation, resistin expression was notlimitedtoperisinusoidallocation(inKupffercells), butitwasdistinctinthemacrophagesinotherpartsof liverlobules.Thisobservationindicatesthatimmune systemcellsarethemainsourceofliverresistin.Additionally, we observed marked expression of resistin inhistiocytes(CD68+)surroundingthesteatotichepatocytes(themoresteatosis,themoremarkedresistin expression). It may suggest the induction of resistin secretionbylipidsinhepatocytesor,conversely,theinductionofhepatocytesteatosisbyresistin-constitute the"firsthit"inNASHdevelopmenttheory.
The results of most studies show higher resistin levelintheserumofpatientswithliversteatosisvs. non-obesecontrols [8, 9, 10] .Higherlevelsofresistin in patients with NAFLD and a positive correlation with inflammation were reported in several studies [8, 11] .However,inotherstudiesthecorrelationbetweenresistinandNAFLDwasnotreported [12, 13, 14] , or even a negative correlation was found [15] . Thesestudieswerebasedonserumlevelofresistin. Therearealimitednumberofstudiesevaluatingresistinexpressiondirectlyintheliver.Shenet al. [4] compared patients with NAFLD (simple steatosis andNASH)vs.controlgroup.Inthatstudy,theserumresistinlevelwasexamined(ELISAtest)aswell asresistinmRNAandimmunohistochemistryinthe liver.Theserumresistinlevelwashigherinpatients with NAFLD, but there was no difference between simple steatosis and NASH. Resistin expression in the liver correlated with NAFLD stage (inflammation,hepatocyteballooning,fibrosis).Similarresults werereportedbyHuanget al. [6] .Theauthorssuggestthatserumresistinlevelreflectsthewhole-body fatstores,andresistinisaccumulatedintheliverand mayplayaroleinaggravationoftheinflammatory process.However,diverseresultsfromdifferentstudiesbasedontheserumlevelofresistinalsosuggest thatthemainsourceofresistinisnotadiposetissue (or macrophages from adipose tissue) but the liver. Weconfirmastrongcorrelationbetweenliverresistin expression in each analysed location and NAFLD (steatosis, hepatocytes ballooning, inflammation) withtheexceptionoffibrosis.
Resistin is regarded as a proinflammatory cytokine. Despite a positive correlation with NAFLD stage, we found no correlation with non-specific markers of inflammation such as CRP, leucocytosis, oranywhitebloodcells.Therearestudieswithsimilar observations as ours [8, 16] ; in some of them, CRPwasaweakpredictivefactorforNAFLD [17] . Elevated AST and ALT levels are often the indicatorofliverinjury.Weobservedacorrelationbetween resistinlevelsandtheseparameters;additionally,we alsofoundacorrelationbetweentotalresistinexpressionandLDHandGGTP.However,thedeRitisindexwasnotsignificant.Andagain,theresultsfrom the literature (usually available only for ALT) are confusing,rangingfromsimilarinNAFLDpatients [18] ,throughnocorrelationatall [19] ,tonegative correlationinobesechildren [20] . Resistinisacytokinethatisfrequentlymentioned asapotentialpathogenicfactorforinsulinresistance, secondarytoobesity.Thisrelationshipwasreported inseveralstudiesonanimalmodels(mouseorrat) [3, 21, 22, 23, 24, 26] .Inhumans,however,theresults arediverse.Inhealthysubjectswithelevatedresistin levels, a higher risk of type 2 diabetes mellitus was noted,especiallyinsubjectswithconcomitantobesity orinflammatoryprocess [27] .Inagroupofpatients withtype2diabetesmellitus,Kaplon-Cieslickaet al. [28] did not show a correlation between serum resistinlevelandBMIorHOMAindex,regardlessof thepatient'ssex.Paganoet al. [8] didnotfindadifferencebetweenserumresistinlevelandinsulinresistanceinNAFLDgroup.Adecreaseinresistinlevel wasreportedafterbariatricsurgeryinafewstudies [29, 30, 31, 32] , usually based on serum level. In astudyMoschenbyet al. [29] thisdecreaseinserum resistinlevelswasseen12monthsafterthesurgery (whilesixmonthsafterthesurgeryanincreaseinserumresistinlevelswasrecorded).Moschenet al.also examined resistin levels directly in the liver, and in this location the decrease was seen earlier -after 6 months.Intheirprospectivestudyofobesepatients with NAFLD and a healthy control group, Shen et al. [4] reportedacorrelationbetweenresistinexpression(serumandliver)andobesitybutnotinsulinresistance.Moststudies,however,arebasedonserum resistinlevels,andtheirresultsareconfusing.Apositive correlation with obesity was reported in many otherstudies [6, 9, 33, 34, 35, 36, 37, 38, 39] ,but still in many others no such correlation was found [8, 13, 40, 41] .Similarly,manystudiesshowapositive correlation with insulin resistance [9, 33, 34, 35, 39, 41] ,whileothersreportconflictingobservations [8, 10, 11, 13, 36, 37, 40] .Inobeseteenagers withinitiallyhigherlevelofresistin,thedecreasein resistinlevelswasobservedsixmonthsafterchangingbadhabits [6] .Ourresultsadditionallysupport the claim that there is a link between resistin and glucosemetabolism.Inmostlocations(especiallyfor totalresistinexpression),therewasacorrelationwith glucose,HbA 1c ,insulin,andHOMAindex.Onlyin Kupffercellswastherenocorrelationwithinsulinresistance.Generally,whenanalysingtheresultsofour study,wehadanimpressionthatthislocationwasthe mostconstantandchangelessofallpartsoftheliver resistinexpression.Inmoststudiescomparingobese patientswithnon-obesecontrols,asignificantdifference was found. However, when a comparison was made inside the obese group, most authors did not reportcorrelationwithBMI.WethinkthatthestatisticallysignificantcorrelationwithBMIinsidethe obesegroup(fortotalresistinexpression)inourstudy resultsfromthesizeofourgroup.Theobservationof patientsfollowingbariatricsurgery [29, 30, 31, 32] , whereallstudiesreportthedecreaseinresistinlevel after one year, also supports our results. Obviously, currentlyitisnotpossibletoverifywhetherresistin can be responsible for weight gain, or whether it is onlyitsconsequence.Weassumethattheremustbe aconnectionwithhepaticinsulinresistance.Perhaps, the liver is the target organ for resistin. HOMA is oneofthemostcommonlyappliedindicesofinsulin resistance;however,itisanindexofperipheraland hepatic insulin resistance. In a study by Bajaj et al. [10] serumresistinlevelcorrelatedwithfataccumulationintheliverandhepaticinsulinresistance(not peripheral)inpatientswithtype2diabetesmellitus. An additional observation made during our study is the analysis of the diabetic group, revealing that there was no difference with metformin intake. We did not find any similar analysis in the literature. A positive role of metformin in NAFLD treatment hasbeenpostulated,but(ifso)itisnotaprocessinvolvingresistin.
Otherpathologies,probablyrelatedtoresistin,are disturbances in the lipid metabolism. The results of ourstudygenerallysupportthistheory.Wenotedarelationshipbetweenliverresistinexpressionandserum triglycerideslevelanddyslipidaemia(withtheexceptionofKupffercells).InKupffercells,higherresistin expressionwasobservedatlowerHDL-Clevels.These observations can also be attributed to insulin resistance-wheninsulinresistanceincreases,HDLlevels decrease and triglyceride levels rise. Several populationstudiesshowedthatcholesterollevel(totalandall fractions)waslowerathigherresistinconcentration(in obese,NAFLD,anddiabeticpatients) [39, 42] .Similarfindingswerereportedinstudiesonrats,whereexcessiveresistinexpressionledtoadecreaseintotalcholesterolandHDL-C [43] .Theauthorssupposedthat this effect could be related to the accumulation and sequestrationofcholesterolinmacrophages.However, also in lipid metabolism, the results of other studies are conflicting, showing no correlation or a positive correlationwithtotalcholesterolandanegativecorrelationwithHDL-C [44, 45, 46, 47, 48] .
Although some studies suggest a role of iron in liverfibrosisandinsulinresistance,wefoundnocorrelationwiththeparametersrelatedtoironmetabolism-Hgb,MCV,Fe,TIBC,transferrin,orferritin. Nosuchstudieshavebeenreportedintheliterature.
Vitamin B 12 is responsible for DNA methylation and plays different roles in humans. Among metformin-treated patients with type 2 diabetes mellitus,adecreaseinvitaminB 12 levelwasobserved [49, 50] .InpatientswithlowvitaminB 12 level,unfavourablechangesinlipidsalsotakeplace,withanincrease in total cholesterol and LDL-C and a decrease in HDL-C [49] .Inoneofstudy [51] theauthorssuggestapotentialprotectiveroleofvitaminB 12 -inrats fedwithNDMA(N-nitrosodimethylamine),vitamin B 12 improved liver parameters. In our study there was a correlation between serum vitamin B 12 level andresistinexpressioninmacrophagesandKupffer cells (statistically significant). No such analyses are availableintheliterature.
In conclusion, we presume that resistin aggravatespathologicchangesintheliverofpatientswith NAFLD.Wealsoconfirmthatresistinplaysarolein thepathogenesisofhepaticinsulinresistance.There are still many question marks regarding the role of resistinanditsmetabolism.Webelievethattheresultsofourstudywillbeofvalueforfurtheranalyses sincethegroupofourpatientsisoneofthelargest reportedinliterature.
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